תפריט כתבה
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
CBS
03:44, עידכון: 04:20
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
